Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / PLX - Amicus Therapeutics: An Inflection Point In Growth

PLX - Amicus Therapeutics: An Inflection Point In Growth

Protalix BioTherapeutics Inc.
  • Despite the bear market, Amicus Therapeutics is enjoying aggressive sales growth for its lead medicine, Galafold, for Fabry.
  • By mid-year, you are most likely to see another approval, that is, AT-GAA for Pompe disease.
  • As it's operating at a growth inflection point, you should pick up more Amicus shares to enjoy the substantial upsides.

For further details see:

Amicus Therapeutics: An Inflection Point In Growth
Stock Information
Company Name: Protalix BioTherapeutics Inc.
Stock Symbol: PLX
Market: NYSE
Website: protalix.com
Menu
PLX PLX Quote PLX Short PLX News PLX Articles PLX Message Board
Get PLX Alerts

News, Short Squeeze, Breakout and More Instantly...